ETC

Recommend
Index
  • Aggrastat®

    Aggrastat®

    Ingredient

    Each mL contains Tirofiban Hydrochloride Monohydrate-0.281mg (as Tirofiban
    0.25mg)

    Content

    0.25mg/mL

    Indication

    AGGRASTAT, in combination with heparin,
    is indicated for the treatment of acute coronary syndrome, including patients
    who are to be managed medically and those undergoing percutaneous transluminal
    coronary angioplasty (PTCA) or atherectomy. In this setting, AGGRASTAT has been
    shown to decrease the rate of a combined endpoint of death, new myocardial
    infarction or refractory ischemia/repeat cardiac procedure.

TOP